IS8097A - Blanda af örvandi módafíníli og geðdeyfðarlyfi til meðhöndlunar á þunglyndi - Google Patents

Blanda af örvandi módafíníli og geðdeyfðarlyfi til meðhöndlunar á þunglyndi

Info

Publication number
IS8097A
IS8097A IS8097A IS8097A IS8097A IS 8097 A IS8097 A IS 8097A IS 8097 A IS8097 A IS 8097A IS 8097 A IS8097 A IS 8097A IS 8097 A IS8097 A IS 8097A
Authority
IS
Iceland
Prior art keywords
modafinil
antidepressants
stimulant
depression
mixture
Prior art date
Application number
IS8097A
Other languages
English (en)
Icelandic (is)
Inventor
Hassman Howard
J. Hughes Rodney
Original Assignee
Cephalon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon, Inc. filed Critical Cephalon, Inc.
Publication of IS8097A publication Critical patent/IS8097A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8097A 2003-05-13 2005-10-27 Blanda af örvandi módafíníli og geðdeyfðarlyfi til meðhöndlunar á þunglyndi IS8097A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46994303P 2003-05-13 2003-05-13
US10/844,187 US20040229942A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations
PCT/US2004/015194 WO2004100937A1 (en) 2003-05-13 2004-05-13 Combination of the analeptic modafinil and an antidepressant for the treatment of depression

Publications (1)

Publication Number Publication Date
IS8097A true IS8097A (is) 2005-10-27

Family

ID=33423928

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8097A IS8097A (is) 2003-05-13 2005-10-27 Blanda af örvandi módafíníli og geðdeyfðarlyfi til meðhöndlunar á þunglyndi

Country Status (24)

Country Link
US (1) US20040229942A1 (enExample)
EP (1) EP1628652B1 (enExample)
JP (1) JP5553955B2 (enExample)
KR (1) KR20060019537A (enExample)
AR (1) AR045423A1 (enExample)
AU (1) AU2004238379B2 (enExample)
BR (1) BRPI0411174A (enExample)
CA (1) CA2525524C (enExample)
CY (1) CY1113154T1 (enExample)
DK (1) DK1628652T3 (enExample)
EA (1) EA012173B1 (enExample)
ES (1) ES2390225T3 (enExample)
HR (1) HRP20120713T1 (enExample)
IS (1) IS8097A (enExample)
MX (1) MXPA05012144A (enExample)
MY (1) MY140179A (enExample)
NO (1) NO334448B1 (enExample)
NZ (1) NZ544135A (enExample)
PL (1) PL1628652T3 (enExample)
PT (1) PT1628652E (enExample)
SI (1) SI1628652T1 (enExample)
TW (1) TWI409061B (enExample)
UA (1) UA89753C2 (enExample)
WO (1) WO2004100937A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2634702C (en) * 2000-07-27 2011-07-19 Teva Pharmaceutical Industries Ltd. Crystalline and pure modafinil, and process of preparing the same
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
SI1575565T1 (sl) 2003-08-08 2010-04-30 Biovail Lab Int Srl Tableta bupropion hidroklorida z modificiranim sprošŽŤanjem
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
JP5395663B2 (ja) * 2006-08-14 2014-01-22 ニューロヒーリング・ファーマシューティカルズ・インコーポレーテッド モダフィニルによる早漏の治療
JP6614014B2 (ja) * 2016-04-26 2019-12-04 信越化学工業株式会社 含窒素オルガノキシシラン化合物およびその製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (enExample) * 1993-06-22 1995-09-08 Lafon Labor
US5933841A (en) * 1996-05-17 1999-08-03 Ameritech Corporation Structured document browser
US5890172A (en) * 1996-10-08 1999-03-30 Tenretni Dynamics, Inc. Method and apparatus for retrieving data from a network using location identifiers
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6359635B1 (en) * 1999-02-03 2002-03-19 Cary D. Perttunen Methods, articles and apparatus for visibly representing information and for providing an input interface
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) * 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
WO2001013921A1 (en) * 1999-08-23 2001-03-01 Ockert David M Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations

Also Published As

Publication number Publication date
NZ544135A (en) 2008-09-26
EP1628652A1 (en) 2006-03-01
CA2525524A1 (en) 2004-11-25
MXPA05012144A (es) 2006-02-08
JP5553955B2 (ja) 2014-07-23
US20040229942A1 (en) 2004-11-18
CA2525524C (en) 2012-09-25
NO334448B1 (no) 2014-03-03
JP2007505156A (ja) 2007-03-08
AU2004238379B2 (en) 2009-08-20
WO2004100937B1 (en) 2006-12-21
WO2004100937A1 (en) 2004-11-25
EP1628652B1 (en) 2012-07-11
EA012173B1 (ru) 2009-08-28
PT1628652E (pt) 2012-09-28
CY1113154T1 (el) 2016-04-13
ES2390225T3 (es) 2012-11-07
NO20055450L (no) 2006-02-01
NO20055450D0 (no) 2005-11-17
BRPI0411174A (pt) 2006-07-18
HRP20120713T1 (hr) 2012-09-30
AU2004238379A1 (en) 2004-11-25
TW200500063A (en) 2005-01-01
DK1628652T3 (da) 2012-10-08
UA89753C2 (ru) 2010-03-10
HK1087645A1 (en) 2006-10-20
KR20060019537A (ko) 2006-03-03
PL1628652T3 (pl) 2012-12-31
TWI409061B (zh) 2013-09-21
SI1628652T1 (sl) 2012-11-30
EA200501802A1 (ru) 2006-06-30
MY140179A (en) 2009-11-30
AR045423A1 (es) 2005-10-26

Similar Documents

Publication Publication Date Title
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1698640T4 (da) Fremgangsmåde til stabilisering af antistof og antistofpræparat som stabiliseret opløsning.
DE60300980D1 (de) Lochmikromischer
DK1427730T3 (da) Nye dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
DE60308941D1 (de) Mischer
DK1480955T3 (da) O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
DK1740197T3 (da) Prolyl-endopeptidease (PEP) og glutamin-endoprotease til behandlingen af cøliaki
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK1516053T3 (da) Xylanaser, nucleinsyrer, som koder herfor, og fremgangsmåder til at fremstille og benytte disse
NO20044662L (no) Forbindelser, blandinger og fremgangsmater
CY1108747T1 (el) Παρασκευες ενος σουλφινυλο ακεταμιδιου
NO20042906L (no) Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
IS8097A (is) Blanda af örvandi módafíníli og geðdeyfðarlyfi til meðhöndlunar á þunglyndi
IS8098A (is) Blanda af örvandi módafíníli og geðdeyfðarlyfi til meðhöndlunar á þunglyndi
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1611884T3 (da) Plaster, indeholdende diclofenac
NO20042907L (no) Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
DK1758840T3 (da) Zeolit-beta-katalysator og fremgangsmåde til fremstilling af katalysatoren
IS8327A (is) Módafíníl breyttar losaðar lyfjasamsetningar
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi